Soleus Capital Management’s Incyte INCY Stock Holding History

Soleus Capital Management’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-79,700	Closed	-$6.05M	–	81
2022 Q2	$6.05M	Buy	+79,700	New	+$6.05M	0.94%	35

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Soleus Capital Management's INCY Position: Q3 2022 in Review

Soleus Capital Management sold out of Incyte (INCY) in Q3 2022, closing a stake of 79,700 shares — an estimated $6.05M sold.

Soleus Capital Management first reported a position in INCY in Q2 2022 and held it in 1 quarter. The position peaked at $6.05M in Q2 2022. 536 funds tracked by Wall St. Rank hold INCY as of Q3 2022.

Soleus Capital Management reported no remaining Incyte position as of Q3 2022 after selling out during the quarter.
Soleus Capital Management sold 79,700 Incyte shares in Q3 2022, an estimated $6.05M.
Soleus Capital Management first reported a position in Incyte in Q2 2022 and held it in 1 quarter.
Soleus Capital Management's Incyte position peaked at $6.05M in Q2 2022.
536 funds tracked by Wall St. Rank held Incyte as of Q3 2022.

Based on Soleus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.